Topical treatment of diabetic retinopathy: a systematic review.

Acta Ophthalmologica
Mikkel S ThagaardJakob Grauslund

Abstract

Diabetic retinopathy (DR) is the most common microvascular complication in diabetes and may cause severe visual impairment. Until late stages of DR, treatment options are limited. The aim of the present review was to investigate whether changes of DR might be influenced by topical treatment with eye drops. This systematic review included both randomized and non-randomized human clinical studies on the subject. A systematic search of PubMed Medline, Embase and Scopus databases yielded 710 studies. No inclusion criteria regarding classification of DR were defined. Reference lists as well as first authors were screened for the inclusion of additional studies. Potential bias of the randomized studies was assessed using the Cochrane Risk of Bias tool. Nineteen studies suitable for inclusion were identified. Seven studies were randomized trials. These examined 11 different pharmacological groups of drugs in DR. A favourable effect of corticosteroid eye drops in diabetic macular oedema (DMO) was reported in four studies, and another study reported a positive trend. Eye drops with non-steroidal anti-inflammatory drugs were also reported to have a favourable effect in DMO, but not in non-center involving DMO. Application of neuroprotect...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Nov 25, 2006·Ophthalmology·UNKNOWN Diabetic Retinopathy Clinical Research NetworkPäivi H Miskala
May 26, 2007·The Journal of Pharmacy and Pharmacology·Thorsteinn LoftssonEinar Stefánsson
Apr 18, 2008·Current Medical Research and Opinion·Lauren J LeeHoward G Birnbaum
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Aug 12, 2009·Clinical Ophthalmology·David Callanan, Patrick Williams
Jun 1, 2008·Clinical Ophthalmology·Bruce I Gaynes, Anne Onyekwuluje
Sep 9, 2009·Expert Opinion on Pharmacotherapy·J Jones, P Francis
Feb 25, 2010·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sakiko NakanoHidetoshi Yamashita
Mar 2, 2010·American Journal of Ophthalmology·Peter A CampochiaroHenry H Hsu
Oct 29, 2010·Investigative Ophthalmology & Visual Science·Henry F EdelhauserWai T Wong
Dec 2, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Tetsuya TajikaHideyuki Sakaki
Jan 15, 2011·Acta Ophthalmologica·Sakiko Nakano GotoHidetoshi Yamashita
Sep 29, 2011·Investigative Ophthalmology & Visual Science·Masaki TanitoAkihiro Ohira
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
Jan 4, 2015·BMJ : British Medical Journal·Larissa ShamseerUNKNOWN PRISMA-P Group
Jan 21, 2015·Retina·Scott M FriedmanUNKNOWN Diabetic Retinopathy Clinical Research Network
May 6, 2015·Progress in Retinal and Eye Research·Rafael Simó, Cristina Hernández
Aug 25, 2015·International Ophthalmology·Savleen KaurNishant Sachdev
Apr 2, 2016·Ophthalmic Research·Karoline Boegeberg JonssonJakob Grauslund
Sep 28, 2016·Clinical Interventions in Aging·Andrzej GrzybowskiValentín Huerva
Dec 24, 2016·European Journal of Ophthalmology·Antonio PinnaFrancesco Boscia
Mar 31, 2017·Journal of Endocrinological Investigation·C HernándezR Simó
Nov 10, 2017·Current Eye Research·Ferhat EvliyaoğluMustafa Nuri Elçioğlu
Apr 21, 2018·The Journal of Pharmacy and Pharmacology·Hubert NguyenCrispin R Dass
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kritika Nayak, Manju Misra
Nov 6, 2018·Diabetes·Rafael SimóUNKNOWN European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR)
Mar 8, 2019·Scientific Reports·Yoshiro MinamiAkitoshi Yoshida
Jun 9, 2019·Ophthalmology Retina·Khalil Ghasemi FalavarjaniSayyed Amirpooya Alemzadeh
Sep 13, 2019·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ruth Ibán-AriasKyriaki Thermos
Dec 6, 2019·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Kathrine Kleis Tilma, Toke Bek

❮ Previous
Next ❯

Citations

Aug 29, 2021·Pharmaceutics·Rafael SimóCristina Hernández

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.